Alzheimer's Disease and Dementia

The 17th International Conference on Alzheimer's Disease and Dementia, to be held in Edinburgh, Scotland on June 19-20, 2023, will bring together experts from around the world to share the latest research findings and advancements in the field of Alzheimer's and Dementia. The Alzheimers conference theme: Aims to raise awareness of Alzheimer’s disease and Dementia.

We are thrilled to announce some of the keynote speakers and their topics that will be featured at the conference. Precious Igbinigie, from the University of Wolverhampton, UK, will present on the association of egg consumption with the risk and prognosis of dementia among the older population. Marie Christine Le Bourdais, from the Alzheimer Society of Montreal, will discuss the results of a participatory research project on addressing stigma through virtual film screenings and panel discussions on dementia.

Jing Jiang, from the Beijing University of Chinese Medicine, will talk about the effects and value of Chinese medicine nursing in Alzheimer's disease. Assist Prof Dr. Murugaiyan Gopal, from Harvard Medical School, will present on the therapeutic targeting of microRNAs in multiple sclerosis. Kelli Mauric, from Balance the Brain Professional Corp, will discuss the importance of estradiol in female cognitive function via neuroplasticity in the neuroendocrine system.

Erin Sheehan, from the University of Massachusetts Amherst, will share her insights on a quality improvement project for co-occurring disorders in outpatient behavioral health. Finally, Dr. Ghassan Taraben, an American Board Certified Neurologist & Spinal Interventionist, will dispel the common misconception that dementia and Alzheimer's are a normal part of aging.

The 17th International Conference on Alzheimer's Disease and Dementia promise to be an exciting and informative event, with an array of topics to be covered by distinguished speakers from various fields. We look forward to welcoming you to Edinburgh in June 2023 for what is sure to be an enriching experience.

Market analysis Report

The market for treatments for Alzheimer's disease is projected to increase at a CAGR of 12.19% between 2022 and 2028, from $3.59 billion in 2022 to $7.16 billion in 2028.

In 2021, estimations show that China had the highest prevalence of Alzheimer's disease, followed by the United States and Japan. The total prevalent cases increased from 29,460,996 in 2021 to 36,009,144 cases in 2028. The global market for treatments for Alzheimer's disease is expanding as the condition becomes more common. In the US alone, 900,000 additional individuals are estimated to receive a diagnosis each year.

Why attend

We endeavor to make Alzheimer's disease 2023 a fruitful culmination, with your assistance and magnificent conversations from both Alzheimer's disease and Dementia people groups. Over the meeting, we promise you that you will meet top-grade researchers and convenience at the meeting.

The Conference will feature many invigorating educational undertakings including various sheets, studios, enjoying bundle snacks, paper presentations, and coherent meetings by sensory system-trained professionals and neurosurgeons from everywhere in the country.

Our Benefits

• One on One Meeting with Famous Speakers from 40 Nations
• Live Streaming of the meeting
• World's most well-known experts in Alzheimer's disease and Dementia research
• Top Enterprises Representation
• Provocative Symposia and studio
• Meeting studios in each and every huge country
• Choices for Best Banner Honor
• Noteworthy Youthful Specialist Grant
• Bunch Registration Benefits